TCBP Stock Forecast and Price Predictions 2025, 2030: Is TCBP a buy or hold?
See the latest TCBP stock forecast and price prediction 2025, 2026, 2027, 2028, 2029 and 2030. You will also get other useful information about the TC BioPharm (Holdings) PLC stock that will guide your investment decision.
What kind of stock is TCBP?
TCBP is Depositary Receipt Common Stock of the TC BioPharm (Holdings) PLC, a UK-based clinical-stage Biopharmaceutical Company focusing on making new immunotherapy products relating to its proprietary allogeneic GD-T cell platform.
Established 2013 with headquarters in Scotland, United Kingdom, the Company has since then expanded into five different geographical locations with over 100 employees. TC BioPharm stock started trading on the NASDAQ under the symbol ‘TCBP’ on February 10, 2022.
Why the sudden upward movement in TCBP stock price?
According to a statement by the Company on Tuesday, six patients have so far been dosed in the trial at a higher level, with five receiving second doses and two receiving third doses. Meaning there is a breakthrough in a new therapy.
This announcement had positive influence on investors’ sentiment. TCBP suddenly stock gained over 20% since noon of yesterday after the Company’s announcement of a breakthrough in its complete Phase 2b study of its therapy candidate TCB008.
Will TCBP stock go up?
Valuation metrics and market fundamentals suggest TCBP will go up. The recent surge in TCBP price as a result of breakthrough in TC vaccine will keep market sentiment positive with a prospect for long term growth.
The 9 analysts with 12-month price forecasts for TCBP stock have average target of $8.29, with a low estimate of $1.23 and a high estimate of $9.71.
RECOMMENDED POST: DG Stock Forecast and Price Prediction 2024, 2025, 2026-2030: Is DG stock a good pick?
The average target predicts an increase of 13.87% from the current stock price of $7.28. This means that analysts believe the TCBP will go up.
Another forecast range from a low of $1.40 to a high of $9.56 with an average forecast price target of $7.83. The average target predicts an increase of 8.24% from the current stock price of $7.28. This is a pointer that TCBP is likely to go up.
Is the TCBP stock undervalued or overvalued
The intrinsic value of TCBP stock under the Base Case Scenario is reported to be $10.31. Since the current market price of TCBP is $7.28, TC BioPharm (Holdings) Plc Stock is undervalued by 41.62%.
TCBP currently has a negative Diluted EPS of -199.55. Also, the current negative ROE of -1,217.48% implies that shareholders are losing on their investment in TCBP. This is usually not a good sign for the company’s financial health.
Negative ROE and EPS is not a big deal if TC BioPharm (Holdings) Plc rising costs are a result of the ongoing research and development of new vaccines. With the prospect of breakthroughs in the coming days the company is expected to hit bigger revenues. This will have impact on the stock value.
Is TCBP stock a buy or hold?
Based on our recent forecast, TCBP is a buy. And considering the industry-wide position of TC BioPharm (Holdings) Plc, TCBP stock is a buy candidate.
The price of TCBP stock is expected to increase by 8.24% in the coming year. In effect, analysts consider TCBP stock as a good investment that has potential for long term growth.
READ ALSO: SAVE Stock Forecast and Price Prediction 2024, 2025-2030: Is SAVE a good pick now?
According to 13 Analysts trailing 12-month price targets for TCBP issued before the last split, TCBP has a consensus rating of a strong buy based on 9 buy ratings, 3 hold ratings and 1 sell ratings.
17 Moneystics Analysts consensus rating of 11(64.70%) are recommending TCBP as a Strong Buy, 4(23.52%) are recommending TCBP as a Buy, 2 (11.77%) are recommending TCBP as a hold, and 0 (0.00%) are recommending TCBP as a sell.
TCBP Stock Forecast and Price Predictions 2025, 2030
The price of TCBP stock today is $7.28. Moneystics Stock predictions algorithm uses machine learning and in-depth learning technologies for TCBP stock.
Our model uses historical TCBP price data, volume, financial statements, market sentiment and broader economic conditions.
TCBP Monthly Price Forecast 2025
| Year | Average Price $ | Opening Price $ | High $ | Low $ | Closing Price $ | %Change |
| January | 7.02 | 6.24 | 7.86 | 6.40 | 7.86 | 25.90% |
| February | 6.87 | 7.39 | 7.82 | 6.10 | 6.57 | -11.10% |
| March | 6.45 | 6.76 | 7.53 | 6.29 | 7.08 | 4.88% |
| April | 7.04 | 7.81 | 7.90 | 6.59 | 6.28 | -19.59% |
| May | 7.23 | 6.54 | 8.06 | 6.73 | 7.93 | 21.25% |
| June | 7.98 | 8.03 | 8.49 | 6.04 | 8.36 | 4.11% |
| July | 8.63 | 8.87 | 9.58 | 6.21 | 9.41 | 6.10% |
| August | 8.38 | 9.06 | 9.41 | 6.48 | 7.80 | -13.90% |
| September | 7.13 | 7.90 | 8.07 | 6.67 | 6.79 | -14.02% |
| October | 7.86 | 7.53 | 8.47 | 6.29 | 8.44 | 12.08% |
| November | 8.97 | 8.85 | 9.77 | 7.13 | 9.50 | 7.34% |
| December | 10.13 | 10.53 | 10.86 | 7.41 | 9.73 | -7.60% |
The above estimates show that TCBP stock will reach an average price of $10.13 per share in December 2025, meaning that by the end of the year 2025, TCBP will trade at $10 per share. This represents 39.15% increase from the current price.
TCBP Monthly Price Forecast 2026
| Year | Average Price $ | Opening Price $ | High $ | Low $ | Closing Price $ | %Change |
| January | 8.78 | 9.17 | 10.05 | 8.13 | 8.66 | -5.61% |
| February | 8.56 | 9.04 | 9.40 | 8.34 | 8.28 | -8.41% |
| March | 9.37 | 8.95 | 10.21 | 8.40 | 9.64 | 7.71% |
| April | 9.33 | 9.28 | 9.66 | 8.72 | 9.44 | 1.70% |
| May | 10.02 | 9.61 | 10.57 | 8.60 | 10.19 | 6.04% |
| June | 10.43 | 10.39 | 11.80 | 8.83 | 11.45 | 10.20% |
| July | 11.17 | 11.32 | 11.97 | 9.42 | 10.56 | -6.71% |
| August | 10.59 | 10.20 | 12.03 | 9.66 | 11.79 | 15.59% |
| September | 11.27 | 11.25 | 12.65 | 9.49 | 12.52 | 11.29% |
| October | 11.76 | 12.05 | 12.36 | 9.29 | 10.67 | -11.45% |
| November | 10.62 | 10.78 | 11.83 | 10.07 | 11.46 | 6.31% |
| December | 12.10 | 11.73 | 12.70 | 10.86 | 12.34 | 5.20% |
The above estimates show that TCBP stock will reach an average price of $12.10 per share in December 2026, meaning that by the end of the year 2026, TCBP will trade at $12 per share. This represents 66.21% increase from the current price.
TCBP Yearly Price Prediction 2027, 2028, 2029, 2030
| Year | Average Price $ | Opening Price $ | High $ | Low $ | Closing Price $ | Total %Change |
| 2027 | 13.05 | 12.27 | 15.28 | 10.76 | 14.69 | 19.72% |
| 2028 | 16.21 | 15.38 | 18.04 | 11.67 | 17.57 | 14.24% |
| 2029 | 15.60 | 16.83 | 17.50 | 12.91 | 15.86 | -5.76% |
| 2030 | 18.26 | 17.59. | 19.79 | 13.17 | 19.40 | 10.29% |
The above estimates show that TCBP stock will reach an average price of $13.50 per share in 2027, with a low of $10.76 and a high of $15.28. The average price estimate represents 85.44% increase from the current price.
PEOPLE ALSO READ: Viatris stock (VTRS) stock price prediction 2024, 2025-2030: Is VTRS a buy?
In 2028, TCBP will reach average price of $16.21 per share, with a low of $11.67 and $18.04 high. The average price estimate represents 122.66% increase from the current price.
In 2029, TCBP will reach average price of $15.60 per share, with a low of $12.19 and $17.50 high. The average price estimate represents 114.29% increase from the current price.
In 2030, TCBP will reach average price of $18.26 per share, with a low of $13.17 and $19.79 high. The average price estimate represents 150.82% increase from the current price.
Should you invest $1000 in TCBP today, where will you be in 2027?
From our forecast and predictions, the estimated average price of TCBP in 2027 is $13.05 per share.
This implies that in 2027 TCBP will trade at $13 per share as against the current price of $7.28. The estimated average price is 85.44% above the current price.
Therefore, $1000 today gives you power to buy about 137.36 units of TCBP shares. Keeping the same units of TCBP stock till 2027 gives you $13 x 137.36 = $1,786. This means you will be $786 richer in 2027.
Is TCBP stock a good deal? Yeah!
With a long term growth forecast and volatility below industry average, TCBP stock should be a good pick for growth investors.
